Greenwich, CT, United States of America

Roman Wolfgang Fleck

USPTO Granted Patents = 5 

Average Co-Inventor Count = 11.7

ph-index = 4

Forward Citations = 112(Granted Patents)


Company Filing History:


Years Active: 2005-2008

Loading Chart...
5 patents (USPTO):Explore Patents

Title: An Insight into the Innovative Mind of Roman Wolfgang Fleck

Introduction

Roman Wolfgang Fleck is a prominent inventor based in Greenwich, Connecticut, who has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Fleck's innovations primarily focus on compounds that have potential therapeutic applications in treating autoimmune diseases, inflammatory diseases, and cancer.

Latest Patents

Fleck's latest patents include two groundbreaking inventions. The first patent involves "Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses." This invention discloses substances that serve as inhibitors of the kinase activity of the IκB kinase (IKK) complex, indicating their utility in managing different IKK-mediated diseases.

The second patent is titled "Substituted tricyclic heterocycles and their uses." This patent highlights compounds that possess anti-inflammatory properties, making them valuable in the treatment of various disorders characterized by inflammation. Both patents demonstrate Fleck's commitment to addressing pressing healthcare challenges.

Career Highlights

Roman Wolfgang Fleck is currently associated with Boehringer Ingelheim Pharmaceuticals, Inc., a company known for its focus on discovering and developing innovative therapies. His work within this esteemed organization has allowed him to pioneer advancements in drug development, particularly in the pharmaceutical industry.

Collaborations

Throughout his career, Fleck has had the opportunity to work alongside notable colleagues such as Charles Lawrence Cywin and Peter Allen Nemoto. These collaborations have likely fostered a creative and innovative environment that has contributed to the development of his patents and scientific advancements.

Conclusion

Roman Wolfgang Fleck exemplifies the spirit of innovation within the pharmaceutical industry. His dedication to developing new compounds with therapeutic applications has the potential to transform treatment options for patients with critical health conditions. As he continues his work at Boehringer Ingelheim Pharmaceuticals, his contributions to science and medicine are undoubtedly poised to make a lasting impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…